• Align Technology, Inc. was removed from the FTSE All-World Index in March 2026, a change that can influence index-tracking fund holdings and passive investment flows.
• This index exclusion matters because it may alter how large institutional investors gain exposure to Align, potentially shifting the company’s shareholder base and liquidity profile.
• We’ll now examine how Align’s removal from the FTSE All-World Index may influence its longer-term investment narrative and risk-reward profile.

Rare earth metals are the new gold rush. Find out which 26 stocks are leading the charge.

Align Technology Investment Narrative Recap

To own Align, you have to believe in sustained demand for clear aligners and digital dentistry, supported by ongoing product innovation and doctor adoption. The FTSE All-World exclusion primarily affects how some passive funds trade the stock and, by itself, does not change the current key near term drivers: how resilient case volumes are and whether pricing and mix pressures continue to weigh on margins.

The most relevant recent announcement here is Align’s 2026 revenue guidance of 3% to 4% growth and Q1 2026 revenue guidance of US$1,010 million to US$1,030 million. Those figures frame what many investors see as the key catalyst: whether Align can stabilize growth and profitability despite softer case starts and lower priced product mix, at a time when index removal could also influence trading liquidity and sentiment.

Yet while index changes can look technical, investors should be aware of how they intersect with pressures on Align’s pricing and product mix...

Align Technology's narrative projects $4.7 billion revenue and $727.3 million earnings by 2029. This requires 5.0% yearly revenue growth and a $316.9 million earnings increase from $410.4 million today.

Uncover how Align Technology's forecasts yield a $201.69 fair value, a 14% upside to its current price.

Exploring Other Perspectives

While consensus focuses on modest 3% to 4% growth, some bullish analysts were penciling in about US$4.7 billion of revenue and US$707.7 million of earnings by 2028, which is a far more optimistic path that the latest index removal may prompt you to reassess in light of ongoing margin and demand risks.

Explore 6 other fair value estimates on Align Technology - why the stock might be worth as much as 27% more than the current price!

Form Your Own Verdict

Don't just follow the ticker - dig into the data and build a conviction that's truly your own.

• A great starting point for your Align Technology research is our analysis highlighting 2 key rewards and 1 important warning sign that could impact your investment decision.
• Our free Align Technology research report provides a comprehensive fundamental analysis summarized in a single visual - the Snowflake - making it easy to evaluate Align Technology's overall financial health at a glance.

Looking For Alternative Opportunities?

These stocks are moving-our analysis flagged them today. Act fast before the price catches up:

• AI is about to change healthcare. These 36 stocks are working on everything from early diagnostics to drug discovery. The best part - they are all under $10b in market cap - there's still time to get in early.
• Find 61 companies with promising cash flow potential yet trading below their fair value.
• We've uncovered the 12 dividend fortresses yielding 5%+ that don't just survive market storms, but thrive in them.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.